2023 annual financial data
Century Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,952.93%.
Operating income was -146,546,000 USD and net income was -136,673,000 USD.
Operating cash flow was -88,348,000 USD.
Get free Century Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,235,000 USD
- Operating income
- -146,546,000 USD
- Net income
- -136,673,000 USD
- Operating cash flow
- -88,348,000 USD